open access
Clinical evaluation of transvaginal myomectomy surgery: a retrospective study of 138 cases
Affiliations- Shengjing Hospital of China Medical University, Shenyang, China
- Cancer Hospital of China Medical University, Shenyang, China
open access
Abstract
Objectives: The aim of this study was to evaluate the safety, feasibility, and effectiveness of transvaginal myomectomy surgery.
Material and methods: We conducted a retrospective study in Shengjing Hospital of China Medical University. In all, 138 patients underwent transvaginal myomectomy from March 2009 to March 2019. The perioperative clinical data, such as position and size of myomas, operative duration, blood loss, intraoperative and postoperative complications, and hospitalization time were retrospectively analyzed.
Results: All transvaginal myomectomies were performed without conversion to laparotomy. The mean vaginal operating time was 56.0 (± 17.2) minutes. The mean operative estimated blood loss was 89.2 (± 36.8) mL. No significant intraoperative complications occurred. The median time of intestinal function recovery after operation was 1 day (range 1–4 days). The median time of hospital stay was 4 days (range 3–10 days); 12 (8.7%) patients experienced postoperative morbidity.
Conclusions: Transvaginal myomectomy is a minimally invasive surgery that can be performed without leaving a scar on the body surface. It can be performed safely and effectively by a skilled surgeon in cases with a specific surgical indication for this approach.
Abstract
Objectives: The aim of this study was to evaluate the safety, feasibility, and effectiveness of transvaginal myomectomy surgery.
Material and methods: We conducted a retrospective study in Shengjing Hospital of China Medical University. In all, 138 patients underwent transvaginal myomectomy from March 2009 to March 2019. The perioperative clinical data, such as position and size of myomas, operative duration, blood loss, intraoperative and postoperative complications, and hospitalization time were retrospectively analyzed.
Results: All transvaginal myomectomies were performed without conversion to laparotomy. The mean vaginal operating time was 56.0 (± 17.2) minutes. The mean operative estimated blood loss was 89.2 (± 36.8) mL. No significant intraoperative complications occurred. The median time of intestinal function recovery after operation was 1 day (range 1–4 days). The median time of hospital stay was 4 days (range 3–10 days); 12 (8.7%) patients experienced postoperative morbidity.
Conclusions: Transvaginal myomectomy is a minimally invasive surgery that can be performed without leaving a scar on the body surface. It can be performed safely and effectively by a skilled surgeon in cases with a specific surgical indication for this approach.
Keywords
uterine myomas; natural orifice surgery; vaginal myomectomy
About this articleTitle
Clinical evaluation of transvaginal myomectomy surgery: a retrospective study of 138 cases
Journal
Issue
Article type
Research paper
Pages
617-621
Published online
2019-11-28
Page views
1030
Article views/downloads
927
DOI
Pubmed
Bibliographic record
Ginekol Pol 2019;90(11):617-621.
Keywords
uterine myomas
natural orifice surgery
vaginal myomectomy
Authors
Yinghan Chen
Danbo Wang
Fang Ren
References (21)- De La Cruz MS, Buchanan EM. Uterine Fibroids: Diagnosis and Treatment. Am Fam Physician. 2017; 95(2): 100–107.
- Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22(6): 665–686.
- Glaser LM, Friedman J, Tsai S, et al. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines. Best Pract Res Clin Obstet Gynaecol. 2018; 46: 99–112.
- Dubuisson J. The current place of mini-invasive surgery in uterine leiomyoma management. J Gynecol Obstet Hum Reprod. 2019; 48(2): 77–81.
- Wongpia I, Thinkhamrop J, Seejorn K, et al. Incidence of and risk factors for febrile morbidity after laparoscopic-assisted vaginal hysterectomy. Int J Womens Health. 2014; 6: 385–388.
- Yoong W, Zhao W, Cai H, et al. Vaginal Myomectomy Using the Dührssen (Longitudinal Median Cervical) Incision: A Case Series of 19 Patients. J Minim Invasive Gynecol. 2017; 24(5): 811–814.
- Magos AL, Bournas N, Sinha R, et al. Vaginal myomectomy. Br J Obstet Gynaecol. 1994; 101(12): 1092–1094.
- Rakotomahenina H, Rajaonarison J, Wong L, et al. Myomectomy: technique and current indications. Minerva Ginecol. 2017; 69(4): 357–369.
- Meng L, Li W. The curative effect analysis and nursing measures of the transvaginal myomectomy and transabdominal myomectomy. Pak J Pharm Sci. 2016; 29(6 Suppl): 2281–2285.
- Flyckt R, Coyne K, Falcone T. Minimally Invasive Myomectomy. Clin Obstet Gynecol. 2017; 60(2): 252–272.
- Flyckt RL. Setting the focus on patient selection for minimally invasive myomectomy: operating times and surgical morbidity in a large database study. Fertil Steril. 2019; 111(6): 1127–1128.
- Moro F, Bitonti G, Mascilini F, et al. Intraoperative transvaginal ultrasound examination during myomectomy. J Ultrasound. 2019; 22(1): 109–110.
- Chittawar PB, Kamath MS. Review of nonsurgical/minimally invasive treatments and open myomectomy for uterine fibroids. Curr Opin Obstet Gynecol. 2015; 27(6): 391–397.
- Arian SE, Munoz JL, Kim S, et al. Robot-assisted laparoscopic myomectomy: current status. Robot Surg. 2017; 4: 7–18.
- Lee D, Kim SKi, Kim K, et al. Advantages of Single-Port Laparoscopic Myomectomy Compared with Conventional Laparoscopic Myomectomy: A Randomized Controlled Study. J Minim Invasive Gynecol. 2018; 25(1): 124–132.
- Rolli R, Favilli A, Acanfora MM, et al. Vaginal myomectomy is a safe and feasible procedure: a retrospective study of 46 cases. J Obstet Gynaecol Res. 2012; 38(9): 1201–1205.
- Faivre E, Surroca MM, Deffieux X, et al. Vaginal myomectomy: literature review. J Minim Invasive Gynecol. 2010; 17(2): 154–160.
- Rovio PH, Heinonen PK. Transvaginal myomectomy with screw traction by colpotomy. Arch Gynecol Obstet. 2006; 273(4): 211–215.
- Stentz NC, Cooney LG, Sammel MD, et al. Association of Patient Race With Surgical Practice and Perioperative Morbidity After Myomectomy. Obstet Gynecol. 2018; 132(2): 291–297.
- Thubert T, Foulot H, Vinchant M, et al. Surgical treatment: Myomectomy and hysterectomy; Endoscopy: A major advancement. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 104–121.
- Wen KC, Horng HC, Wang PH. Hemorrhage: A strong indicator for myomectomy-related complication. J Chin Med Assoc. 2016; 79(8): 413–414.
